Short‐term intermittent energy restriction interventions for weight management: a systematic review and meta‐analysis
Abstract
This systematic review synthesized the available evidence on the effect of short‐term periods of intermittent energy restriction (weekly intermittent energy restriction; ≥7‐d energy restriction) in comparison with usual care (daily continuous energy restriction), in the treatment of overweight and obesity in adults. Six electronic databases were searched from inception to October 2016. Only randomized controlled trials of interventions (≥12 weeks) in adults with overweight and obesity were included. Five studies were included in this review. Weekly intermittent energy restriction periods ranged from an energy intake between 1757 and 6276 kJ/d−1. The mean duration of the interventions was 26 (range 14 to 48) weeks. Meta‐analysis demonstrated no significant difference in weight loss between weekly intermittent energy restriction and continuous energy restriction post‐intervention (weighted mean difference: −1.36 [−3.23, 0.51], p = 0.15) and at follow‐up (weighted mean difference: −0.82 [−3.76, 2.11], p = 0.58). Both interventions achieved comparable weight loss of >5 kg and therefore were associated with clinical benefits to health. The findings support the use of weekly intermittent energy restriction as an alternative option for the treatment of obesity. Currently, there is insufficient evidence to support the long‐term sustainable effects of weekly intermittent energy restriction on weight management.
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Chaos and quantum thermalization
- The Dalton quantum chemistry program system
- Cord Blood Leptin and Adiponectin as Predictors of Adiposity in Children at 3 Years of Age: A Prospective Cohort Study
- Quantitative metabolomics by H-NMR and LC-MS/MS confirms altered metabolic pathways in diabetes
- Stable adiabatic quantum batteries
- A novel self-lipid antigen targets human T cells against CD1c(+) leukemias
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.